Plaquenil 200 Sanofi: Compound Profile
Plaquenil 200 Sanofi is a hydroxychloroquine sulfate pharmaceutical preparation containing 200mg of active compound per tablet. Manufactured by Sanofi, this antimalarial derivative belongs to the 4-aminoquinoline class of compounds and serves as a critical research tool for investigating immunomodulatory mechanisms and dermatological pathways. Research applications focus on its dual antimalarial and anti-inflammatory properties, making it valuable for studying autoimmune conditions and skin disorders in laboratory settings. When sourcing research chemicals from Stroid UK Shop, investigators can access pharmaceutical-grade compounds for comprehensive studies.
Research Applications
Scientists investigate Plaquenil 200 in preclinical models examining lysosomal pH modulation, autophagy regulation, and toll-like receptor signalling pathways. Research demonstrates its ability to interfere with antigen processing and presentation mechanisms, making it valuable for immunological investigations. Dermatological research examines its photoprotective properties and effects on inflammatory cascades in skin tissue models. The compound’s unique pharmacokinetic profile, with extensive tissue distribution and prolonged half-life, provides researchers with sustained experimental conditions. Studies within dermatological research categories often incorporate hydroxychloroquine alongside other investigational compounds. Research teams studying metabolic pathways may cross-reference with SARM research applications when examining tissue-selective effects. Additionally, investigators exploring cellular signalling mechanisms often complement studies with peptide research compounds for comprehensive pathway analysis.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Ingredient | Hydroxychloroquine Sulfate |
| Strength | 200mg per tablet |
| Manufacturer | Sanofi |
| CAS Number | 747-36-4 |
| Molecular Formula | C₁₈H₂₆ClN₃O·H₂SO₄ |
| Storage | Room temperature, dry |
Research Compliance
Plaquenil 200 Sanofi is supplied exclusively for in-vitro research and laboratory analysis. This pharmaceutical preparation is not intended for human consumption, clinical use, or therapeutic applications. Researchers must ensure proper laboratory protocols, safety measures, and regulatory compliance when handling this compound. All studies should be conducted within appropriate research facilities with adequate ventilation and safety equipment. Investigators are responsible for understanding local regulations governing research chemical use and disposal procedures.
